跳至主要内容
临床试验/ISRCTN12285821
ISRCTN12285821已完成不适用

A pragmatic trial examining the effect of compliance upon clinical effectiveness and cost effectiveness of Lapdap (CPG-DDS) when compared to sulfadoxine-pyrimethamine and Co-artem (AM-LU) for the treatment of uncomplicated falciparum malaria in Malawi

K Government - Department for International Development (UK)0 个研究点目标入组 1,500 人开始时间: 2005年6月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Adults and children over the age of six months (and who weigh more than 10 kg) with uncomplicated falciparum malaria
  • 1. Febrile illness
  • 2. Asexual forms of P falciparum on blood slide

排除标准

  • 1. Severe malaria (as defined in World Health Organisation [WHO] guidelines)
  • 2. Clinical evidence of a co-existing infection
  • 3. Hb lower than 7 g/dl
  • 4. Known pregnancy or positive pregnancy test (females over the age of 12)
  • 5. Known G6PD deficiency, HbE or porphyria
  • 6. Breast feeding mothers

研究者

发起方
K Government - Department for International Development (UK)

相似试验